Enteris Biopharma
New drug delivery firm Enteris Biopharma – who rose from the ashes of Unigene to offer the Peptelligence delivery platform to both peptides and small molecule drugs – has made three appointments to its leadership team.
Brian Zietsman will serve as President & Chief Financial Officer at Enteris and has over 20 years of strategic finance and accounting experience, including roles at Enzon Pharmaceuticals, Duff & Phelps and Unigene.
Dr. Nozer Mehta, who also worked at Unigene, will serve as Chief Scientific Officer.
Finally Dr. Paul Shields, with over 24 years of experience in the biopharmaceutical industry, will serve as Vice President of Operations.